Impact Biomedical (IBO) Assets (2022 - 2026)
Impact Biomedical's (IBO) quarterly Assets came in at $17.1 million in Q1 2026, down 14.79% YoY from $20.1 million in Q1 2025, and down 1.83% on a QoQ basis from $17.4 million in Q4 2025.
Impact Biomedical (IBO) Assets (2022 - 2026) Analysis & Trends
Impact Biomedical (IBO) has 5 years of Assets data on file, last reported at $17.1 million in Q1 2026.
- Quarterly Assets fell 14.79% year-over-year to $17.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.1 million (down 14.79% YoY) and the FY2025 annual result came in at $17.4 million, down 14.22% from the prior year.
- Assets fell to $17.1 million in Q1 2026, from $17.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $46.7 million in Q3 2024 to a low of $17.1 million in Q1 2026.
- A 5-year average of $33.0 million and a median of $44.1 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets climbed 3.58% — and 2025, when it slumped 61.01%.
- Tracing IBO's Assets over 5 years: stood at $46.5 million in 2022, then declined by 4.01% to $44.6 million in 2023, then plunged by 54.54% to $20.3 million in 2024, then dropped by 14.22% to $17.4 million in 2025, then fell by 1.83% to $17.1 million in 2026.
- The last three Assets figures came in at $17.1 million (Q1 2026), $17.4 million (Q4 2025), and $18.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Impact Biomedical | 49.54 Mn | 49.53 Mn | 2,000.00 | 16.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.75 Mn |
| Mar 31, 2026 | 17.09 Mn |
| Dec 31, 2025 | 17.41 Mn |
| Sep 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 19.06 Mn |
| Mar 31, 2025 | 20.05 Mn |
| Dec 31, 2024 | 20.29 Mn |
| Sep 30, 2024 | 46.70 Mn |
| Jun 30, 2024 | 44.12 Mn |
| Mar 31, 2024 | 44.36 Mn |
| Dec 31, 2023 | 44.63 Mn |
| Sep 30, 2023 | 45.08 Mn |
| Jun 30, 2023 | 45.99 Mn |
| Dec 31, 2022 | 46.50 Mn |